<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR10">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Patel</surname>
    <given-names>JZ</given-names>
   </name>
   <name>
    <surname>Ahenkorah</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Vaara</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Staszewski</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Adams</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Laitinen</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Navia-Paldanius</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Parkkari</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Savinainen</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>Walczy≈Ñski</surname>
    <given-names>K</given-names>
   </name>
  </person-group>
  <article-title>Loratadine analogues as MAGL inhibitors</article-title>
  <source>Bioorg Med Chem Lett</source>
  <year>2015</year>
  <volume>25</volume>
  <issue>7</issue>
  <fpage>1436</fpage>
  <lpage>1442</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2015.02.037</pub-id>
  <?supplied-pmid 25752982?>
  <pub-id pub-id-type="pmid">25752982</pub-id>
 </element-citation>
</ref>
